Cold-adapted, live attenuated intranasal influenza virus vaccine
- 1 March 2003
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 22 (3) , 273-274
- https://doi.org/10.1097/01.inf.0000057440.24094.ac
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Influenza Pandemic Preparedness Action Plan for the United States: 2002 UpdateClinical Infectious Diseases, 2002
- Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacyVaccine, 2002
- Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experienceThe Pediatric Infectious Disease Journal, 2001
- Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adultsVaccine, 2001
- Correlates of Immune Protection Induced by Live, Attenuated, Cold‐Adapted, Trivalent, Intranasal Influenza Virus VaccineThe Journal of Infectious Diseases, 2000
- The Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in ChildrenNew England Journal of Medicine, 2000
- The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in ChildrenNew England Journal of Medicine, 1998
- Evaluation of Live Attenuated Influenza Vaccines in Children 6-18 Months of Age: Safety, Immunogenicity, and EfficacyThe Journal of Infectious Diseases, 1996
- Development and characterization of cold-adapted viruses for use as live virus vaccinesVaccine, 1985
- Use of Temperature-Sensitive and Cold-Adapted Mutant Viroses in Immunoprophylaxis of Acute Respiratory Tract DiseaseClinical Infectious Diseases, 1980